O
OrbiMed
Private EquityActiveOrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
403
Investments
145
Exits
$13.3B
AUM
36.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for OrbiMed.
Investment Thesis & Strategy
OrbiMed invests in various stages of healthcare companies, from biopharmaceuticals to medical devices and diagnostics, with a focus on the healthcare sector.
Investment Activity
Deals per year over the last 15 years
1
20010
20020
20031
20040
20053
20061
20071
20080
20090
20101
20110
20120
20131
20141
2015Portfolio Companies
Selected investments from their portfolio of 403 companies
B
BioMarin
Biotech · Growth, 0
N
Neurocrine Biosciences
Biotech · Growth, 0
M
MyoKardia
Biotech · Growth, 2015
A
ANI Pharmaceuticals
Biotech · Growth, 2014
R
Radius Health
Biotech · Growth, 2011
E
Esperion Therapeutics
Biotech · Growth, 2008
E
Epizyme
Biotech · Growth, 2007
I
Intercept Pharmaceuticals
Biotech · Growth, 2006
P
Portola Pharmaceuticals
Biotech · Growth, 2006
P
Pacira BioSciences
Biotech · Growth, 2006
A
Acadia Pharmaceuticals
Biotech · Growth, 2004
S
Seagen
Biotech · Growth, 2001
Frequently Asked Questions
OrbiMed focuses on Series B, Series C+ stage investments.
Related Investors
General Atlantic
New York, United States · 268 deals
Kohlberg Kravis Roberts
New York, United States · 205 deals
Blackstone Group
New York, United States · 119 deals
Aisling Capital
New York, United States · 94 deals
Raju Rishi
New York, United States · 77 deals
University Ventures
New York, United States · 63 deals